Works by Ntanasis-Stathopoulos, Ioannis

Results: 172
    1
    2

    Re-evaluation of Mayo 2004 and revised Mayo 2012 staging in patients with AL amyloidosis in the era of new therapies.

    Published in:
    2025
    By:
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Spiliopoulou, Vasiliki;
    • Migkou, Magdalini;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Solia, Eirini;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Courraud, Julie;
    • Nikolaou, Panagiota-Efstathia;
    • Giannouli, Stavroula;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Letter to the Editor
    3
    4
    5
    6
    7
    8

    Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom's Macroglobulinemia after BNT162b2 Booster Vaccination.

    Published in:
    Cancers, 2022, v. 14, n. 23, p. 5816, doi. 10.3390/cancers14235816
    By:
    • Rosati, Margherita;
    • Terpos, Evangelos;
    • Bear, Jenifer;
    • Burns, Robert;
    • Devasundaram, Santhi;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Pavlakis, George N.;
    • Felber, Barbara K.
    Publication type:
    Article
    9
    10

    Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD".

    Published in:
    Cancers, 2022, v. 14, n. 11, p. 2768, doi. 10.3390/cancers14112768
    By:
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kastritis, Efstathios;
    • Hatjiharissi, Evdoxia;
    • Katodritou, Eirini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Verrou, Evgenia;
    • Gavriatopoulou, Maria;
    • Leonidakis, Alexandros;
    • Manousou, Kyriaki;
    • Delimpasi, Sosana;
    • Malandrakis, Panagiotis;
    • Kyrtsonis, Marie-Christine;
    • Papaioannou, Maria;
    • Symeonidis, Argiris;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    11

    Daratumumab May Attenuate Cardiac Dysfunction Related to Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma: A Prospective Study.

    Published in:
    Cancers, 2021, v. 13, n. 20, p. 5057, doi. 10.3390/cancers13205057
    By:
    • Terpos, Evangelos;
    • Stamatelopoulos, Kimon;
    • Makris, Nikolaos;
    • Georgiopoulos, Georgios;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Laina, Ageliki;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Malandrakis, Panagiotis;
    • Delialis, Dimitris;
    • Andreadou, Ioanna;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    12

    Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study.

    Published in:
    Cancers, 2021, v. 13, n. 17, p. 4480, doi. 10.3390/cancers13174480
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Giatra, Chara;
    • Asimakopoulos, Ioannis;
    • Dimou, Maria;
    • Sklirou, Aimilia D.;
    • Ntanasis-Stathopoulos, Ioannis;
    • Darmani, Ismini;
    • Briasoulis, Alexandros;
    • Kastritis, Efstathios;
    • Angelopoulou, Maria;
    • Baltadakis, Ioannis;
    • Panayiotidis, Panayiotis;
    • Trougakos, Ioannis P.;
    • Vassilakopoulos, Theodoros P.;
    • Pagoni, Maria;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    13

    Aberrant Plasma Cell Contamination of Peripheral Blood Stem Cell Autografts, Assessed by Next-Generation Flow Cytometry, Is a Negative Predictor for Deep Response Post Autologous Transplantation in Multiple Myeloma; A Prospective Study in 199 Patients.

    Published in:
    Cancers, 2021, v. 13, n. 16, p. 4047, doi. 10.3390/cancers13164047
    By:
    • Kostopoulos, Ioannis V.;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Rousakis, Pantelis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Panteli, Chrysanthi;
    • Orologas-Stavrou, Nikolaos;
    • Kanellias, Nikolaos;
    • Malandrakis, Panagiotis;
    • Liacos, Christine-Ivy;
    • Papaioannou, Nikos E.;
    • Papanota, Aristea-Maria;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Angelis, Nikolaos V.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania E.;
    • Terpos, Evangelos
    Publication type:
    Article
    14

    A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma.

    Published in:
    Cancers, 2021, v. 13, n. 15, p. 3877, doi. 10.3390/cancers13153877
    By:
    • Papanota, Aristea-Maria;
    • Tsiakanikas, Panagiotis;
    • Kontos, Christos K.;
    • Malandrakis, Panagiotis;
    • Liacos, Christine-Ivy;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Avgeris, Margaritis;
    • Dimopoulos, Meletios-Athanasios;
    • Scorilas, Andreas;
    • Terpos, Evangelos
    Publication type:
    Article
    15

    Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study.

    Published in:
    Cancers, 2021, v. 13, n. 6, p. 1257, doi. 10.3390/cancers13061257
    By:
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Katodritou, Eirini;
    • Kyrtsonis, Marie-Christine;
    • Douka, Vassiliki;
    • Spanoudakis, Emmanouil;
    • Papatheodorou, Athanasios;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Gavriatopoulou, Maria;
    • Makras, Polyzois;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A;
    • Atanackovic, Djordje
    Publication type:
    Article
    16

    Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma.

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3245, doi. 10.3390/cancers12113245
    By:
    • Papadimitriou, Konstantinos;
    • Tsakirakis, Nikolaos;
    • Malandrakis, Panagiotis;
    • Vitsos, Panagiotis;
    • Metousis, Andreas;
    • Orologas-Stavrou, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Pothos, Panagiotis;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Terpos, Evangelos;
    • Tsitsilonis, Ourania E.;
    • Kostopoulos, Ioannis V.
    Publication type:
    Article
    17
    18
    19

    Predictive Factors for Neutralizing Antibody Levels Nine Months after Full Vaccination with BNT162b2: Results of a Machine Learning Analysis.

    Published in:
    Biomedicines, 2022, v. 10, n. 2, p. 204, doi. 10.3390/biomedicines10020204
    By:
    • Papadopoulos, Dimitris;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Evangelakou, Zoi;
    • Malandrakis, Panagiotis;
    • Manola, Maria S.;
    • Gianniou, Despoina D.;
    • Kastritis, Efstathios;
    • Trougakos, Ioannis P.;
    • Dimopoulos, Meletios A.;
    • Karalis, Vangelis;
    • Terpos, Evangelos
    Publication type:
    Article
    20

    tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature.

    Published in:
    Biomedicines, 2021, v. 9, n. 12, p. 1811, doi. 10.3390/biomedicines9121811
    By:
    • Karousi, Paraskevi;
    • Papanota, Aristea-Maria;
    • Artemaki, Pinelopi I.;
    • Liacos, Christine-Ivy;
    • Patseas, Dimitrios;
    • Mavrianou-Koutsoukou, Nefeli;
    • Liosi, Aikaterini-Anna;
    • Kalioraki, Maria-Anna;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Scorilas, Andreas;
    • Terpos, Evangelos;
    • Kontos, Christos K.
    Publication type:
    Article
    21

    The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 8, p. 1, doi. 10.1038/s41408-021-00530-3
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Papanagnou, Eleni-Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis P.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    22

    The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 9, p. N.PAG, doi. 10.1038/s41408-020-00360-9
    By:
    • Gavriatopoulou, Maria;
    • Βoultadaki, Andriani;
    • Koutoulidis, Vassilis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Bourgioti, Charis;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Moulopoulos, Lia-Angela
    Publication type:
    Article
    23

    Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myeloma

    Published in:
    2020
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papatheodorou, Athanasios;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Dialoupi, Ioanna;
    • Roussou, Maria;
    • Kokkali, Nikoletta-Aikaterini;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Letter
    24

    Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantation.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 13, p. 2140, doi. 10.1080/10428194.2023.2253479
    By:
    • Eleutherakis Papaiakovou, Evangelos;
    • Terpos, Evangelos;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despoina;
    • Malandrakis, Panagiotis;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Vasiliki;
    • Kostopoulos, Ioannis V.;
    • Tsitsiloni, Ourania;
    • Tsirigotis, Panagiotis;
    • Dimopoulos, Meletios-Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Article
    25

    Patterns of target organ amyloid deposition in patients with AL amyloidosis; role for diagnosis and prognosis.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 6, p. 1212, doi. 10.1080/10428194.2023.2197537
    By:
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Article
    26
    27
    28
    29

    Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 3, p. 619, doi. 10.1080/10428194.2018.1509323
    By:
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Koloventzou, Ursula;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios C.;
    • Panagiotidis, Ioannis;
    • Gika, Dimitra;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    Article
    30
    31

    Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases.

    Published in:
    2018
    By:
    • Ziogas, Dimitrios C.;
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Fotiou, Despoina;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Tatouli, Ioanna;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Panagiotidis, Ioannis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Case Study
    32
    33

    Evaluating Minimal Residual Disease Negativity as a Surrogate Endpoint for Treatment Efficacy in Multiple Myeloma: A Meta‐Analysis of Randomized Controlled Trials.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 3, p. 427, doi. 10.1002/ajh.27582
    By:
    • Ntanasis‐Stathopoulos, Ioannis;
    • Filippatos, Charalampos;
    • Ntanasis‐Stathopoulos, Anastasios;
    • Malandrakis, Panagiotis;
    • Kastritis, Efstathios;
    • Tsitsilonis, Ourania E.;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria
    Publication type:
    Article
    34

    Central nervous system multiple myeloma: A real‐world multi‐institutional study of the Greek Myeloma Study Group.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 10, p. 1897, doi. 10.1002/ajh.27425
    By:
    • Katodritou, Eirini;
    • Dalampira, Dimitra;
    • Delimpasi, Sosana;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Karaolidou, Fryni;
    • Gkioka, Annita‐Ioanna;
    • Labropoulou, Vasiliki;
    • Spanoudakis, Emmanouil;
    • Triantafyllou, Theodora;
    • Kotsopoulou, Maria;
    • Michalis, Eyrydiki;
    • Vadikolia, Chrysanthi;
    • Papadopoulou, Theodosia;
    • Sevastoudi, Aggeliki;
    • Michael, Michael;
    • Daiou, Aikaterini;
    • Pentidou, Aikaterini;
    • Kostopoulos, Ioannis;
    • Palaska, Vasiliki;
    • Gavriatopoulou, Maria
    Publication type:
    Article
    35

    Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 10, p. 1887, doi. 10.1002/ajh.27414
    By:
    • Kostopoulos, Ioannis V.;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Rousakis, Pantelis;
    • Malandrakis, Panagiotis;
    • Panteli, Chrysanthi;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Angelis, Nikolaos;
    • Spiliopoulou, Vasiliki;
    • Syrigou, Rodanthi‐Eleni;
    • Bakouros, Panagiotis;
    • Dimitrakopoulou, Georgia;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Paschalidis, Nikolaos;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios‐Athanasios;
    • Tsitsilonis, Ourania E.;
    • Terpos, Evangelos
    Publication type:
    Article
    36

    Belantamab mafodotin, lenalidomide, and dexamethasone in transplant‐ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin‐associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 3, p. 502, doi. 10.1002/ajh.27219
    By:
    • Gavriatopoulou, Maria;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Vasiliki;
    • Kanellias, Nikolaos;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Roussou, Maria;
    • Psarros, Giorgos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    37

    Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide‐exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 3, p. 396, doi. 10.1002/ajh.27206
    By:
    • Terpos, Evangelos;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Katodritou, Eirini;
    • Hatjiharissi, Evdoxia;
    • Malandrakis, Panagiotis;
    • Verrou, Evgenia;
    • Golfinopoulos, Stavros;
    • Migkou, Magdalini;
    • Manousou, Kyriaki;
    • Delimpasi, Sosana;
    • Symeonidis, Argiris;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    38

    Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 9, p. E226, doi. 10.1002/ajh.27001
    By:
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Symeonidis, Argiris;
    • Labropoulou, Vasiliki;
    • Delimpasi, Sosana;
    • Mancuso, Katia;
    • Zamagni, Elena;
    • Katodritou, Eirini;
    • Rivolti, Elena;
    • Kyrtsonis, Marie‐Christine;
    • Roussou, Maria;
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Hatjiharissi, Evdoxia;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Cheliotis, Giorgos;
    • Manousou, Kyriaki;
    • Gavriatopoulou, Maria
    Publication type:
    Article
    39

    Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. 730, doi. 10.1002/ajh.26891
    By:
    • Katodritou, Eirini;
    • Kastritis, Efstathios;
    • Dalampira, Dimitra;
    • Delimpasi, Sosana;
    • Spanoudakis, Emmanouil;
    • Labropoulou, Vasiliki;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Gkioka, Annita‐Ioanna;
    • Giannakoulas, Nikos;
    • Kanellias, Nikolaos;
    • Papadopoulou, Theodosia;
    • Sevastoudi, Aggeliki;
    • Michalis, Eyrydiki;
    • Papathanasiou, Maria;
    • Kotsopoulou, Maria;
    • Sioni, Anastasia;
    • Triantafyllou, Theodora;
    • Daiou, Aikaterini;
    • Papadatou, Mavra;
    • Kyrtsonis, Marie‐Christine
    Publication type:
    Article
    40
    41
    42

    Chromosome 1q21 aberrations identify ultra high‐risk myeloma with prognostic and clinical implications.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1142, doi. 10.1002/ajh.26639
    By:
    • Kastritis, Efstathios;
    • Migkou, Magdalini;
    • Dalampira, Dimitra;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Theodorakakou, Foteini;
    • Sevastoudi, Aggeliki;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Triantafyllou, Theodora;
    • Terpos, Evangelos;
    • Katodritou, Eirini;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    43

    Third dose of the BNT162b2 vaccine results in very high levels of neutralizing antibodies against SARS‐CoV‐2: Results of a prospective study in 150 health professionals in Greece.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 4, p. E147, doi. 10.1002/ajh.26468
    By:
    • Terpos, Evangelos;
    • Karalis, Vangelis;
    • Sklirou, Aimilia D.;
    • Apostolakou, Filia;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Bagratuni, Tina;
    • Iconomidou, Vassiliki A.;
    • Malandrakis, Panagiotis;
    • Korompoki, Eleni;
    • Papassotiriou, Ioannis;
    • Trougakos, Ioannis P.;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    44
    45
    46

    Comparison of neutralizing antibody responses against SARS‐CoV‐2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 9, p. E321, doi. 10.1002/ajh.26248
    By:
    • Terpos, Evangelos;
    • Trougakos, Ioannis P.;
    • Karalis, Vangelis;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Sklirou, Aimilia D.;
    • Bagratuni, Tina;
    • Papanagnou, Eleni‐Dimitra;
    • Patseas, Dimitrios;
    • Gumeni, Sentiljana;
    • Malandrakis, Panagiotis;
    • Korompoki, Eleni;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    47

    Hematological findings and complications of COVID‐19.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 7, p. 834, doi. 10.1002/ajh.25829
    By:
    • Terpos, Evangelos;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Elalamy, Ismail;
    • Kastritis, Efstathios;
    • Sergentanis, Theodoros N.;
    • Politou, Marianna;
    • Psaltopoulou, Theodora;
    • Gerotziafas, Grigoris;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    48

    Cell‐free DNA analysis for the detection of MYD88 and CXCR4 mutations in IgM monoclonal gammopathies; an update with clinicopathological correlations.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 6, p. E148, doi. 10.1002/ajh.25802
    By:
    • Ntanasis‐Stathopoulos, Ioannis;
    • Bagratuni, Tina;
    • Gavriatopoulou, Maria;
    • Patseas, Dimitrios;
    • Liacos, Christine;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Tsiligkeridou, Eleni;
    • Andreatou, Amalia;
    • Mavrianou‐Koutsoukou, Nefeli;
    • Migkou, Magdalini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Roussou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    49

    Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 4, p. 400, doi. 10.1002/ajh.25392
    By:
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Christoulas, Dimitrios;
    • Papatheodorou, Athanasios;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Ziogas, Dimitrios C.;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Trougakos, Ioannis P.;
    • Gavriatopoulou, Maria;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    50